CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curium BidCo S.a r.l. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curium BidCo S.a r.l.
Rue Aldringen 13
Luxembourg, 1118  Luxembourg

Business Summary
Curium BidCo S.a r.l., the parent entity of the Curium Group, is a global provider of nuclear medicine and radiopharmaceutical products to imaging centers. The Company focuses on the production and supply of radioactive products and tracers to help enhance diagnostic imaging.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
----YesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Subsidiaries
Business Name Address City State/Province Country
Curium Holding France S.A.S. 12 rue Lord Byron Paris France
Zevacor Molecular 14395 Bergen Boulevard Noblesville IN United States
Curium US LLC 111 West Port Plaza Saint Louis MO United States

Business Names
Business Name
Curium Holding France S.A.S.
Curium US LLC
Institute of Applied Radiopharmacy of Barcelona
Zevacor Molecular


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 24, 2024